Key Points Spectral Ai completed its De Novo application submission to the FDA for the DeepView System in June 2025, marking a major regulatory milestone. Revenue for the quarter declined 32.0% year ...

The American Psychological Association (APA) has called on the Federal Trade Commission to investigate “deceptive practices” ...

As agentic AI advances, it will impact patient-facing healthcare delivery models, while new questions around the ...

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...

According to Ness, the success of HeartFlow’s IPO reflects the market validation of the overall rationale for using AI in ...

FDA staffers aren't making progress with new agency chatbot, billed as a game-changer for lengthy approval processes. - Thomas Fuller / SOPA Images /LightRocket via Getty Images Yahoo is using AI to ...

Sonic Incytes Medical Corp, proudly announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...

Oregon Health & Science University said a trained AI program can detect cancer of a larynx by picking up the distinct ...

Revolution Medicines Inc. (NASDAQ: RVMD) is one of the best upside stocks to invest in now. Earlier on July 23, Revolution ...

Recent news reports highlight uncertainty about pharmaceutical tariffs, an error-prone AI tool in use at the FDA, and scientific research funding in jeopardy.

On June 2, 2025, FDA announced the launch of Elsa, a generative AI tool designed to “help employees—from scientific reviewers to investigators—work more efficiently.” Per FDA, the tool ...

Artificial intelligence programs can help doctors and nurses predict hours earlier which ER patients will likely require ...